Steven Cohen's CBIO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 300,000 shares of Crescent Biopharma, Inc. (CBIO) worth $5.51 M, representing 0.01% of the portfolio. First purchased in 2018-Q2, this short-term holding has been held for 4 quarters.
Based on 13F filings, Steven Cohen has maintained this position in CBIO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 300,000 shares. Largest reduction occurred in Q3 2018, reducing 6,004 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Crescent Biopharma (CBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Crescent Biopharma (CBIO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +300,000 | New Buy | 300,000 | $11.86 |
| Q3 2018 | -6,004 | Sold Out | 0 | $0.00 |
| Q2 2018 | +6,004 | New Buy | 6,004 | $1166.89 |
Steven Cohen's Crescent Biopharma Investment FAQs
Steven Cohen first purchased Crescent Biopharma, Inc. (CBIO) in Q2 2018, acquiring 6,004 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Crescent Biopharma, Inc. (CBIO) for 4 quarters since Q2 2018.
Steven Cohen's largest addition to Crescent Biopharma, Inc. (CBIO) was in Q4 2025, adding 300,000 shares worth $3.56 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 300,000 shares of Crescent Biopharma, Inc. (CBIO), valued at approximately $5.51 M.
As of the Q1 2026 filing, Crescent Biopharma, Inc. (CBIO) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Crescent Biopharma, Inc. (CBIO) was 300,000 shares, as reported at the end of Q4 2025.